Searchable abstracts of presentations at key conferences in endocrinology

ea0050p057 | Bone and Calcium | SFEBES2017

Imaging in primary hyperparathyroidism; does it affect our referral pathways for surgery? Results of an audit

Dede Anastasia , Morganstein Daniel , Shotliff Kevin , Greener Veronica , Smellie James , Maenhout Annelies , Wren Alison

Introduction: The 4th International Workshop on asymptomatic primary hyperparathyroidism (PHPT) has set criteria for surgical intervention and suggests that a percentage of patients can be managed conservatively. Imaging is indicated only pre-operatively to determine the optimal surgical approach.Patients and methods: We completed an audit on the use of Sestamibi, clinical and biochemical data in patients with PHPT.<...

ea0050p065 | Bone and Calcium | SFEBES2017

Primary hyperparathyroidism – A retrospective review

Malhotra Gaurav , Palan Jessal Mitul , Alraheem Ali Abd , Fahey Andrew , Stephenson Kyle , Abott Amanda , Simon Godwin

Primary Hyperparathyroidism is one of the common endocrine disorders seen in an endocrine clinic. We retrospectively analysed patients referred with primary hyperparathyroidism over 1 yr (Oct 2013 - Sept 2014) and followed them over next 30 months. Patients with isolated secondary hyperparathyroidism were excluded. Few had secondary hyperparathyroidism in addition to primary hyperparathyroidism.50 patients with primary hyperparathy...

ea0050ep004 | Adrenal and Steroids | SFEBES2017

An unusual case of acute adrenal insufficiency

James Lucas , Bellankannan Raj , Buch Harit

Adrenal insufficiency is an uncommon endocrine condition with an incidence of 4 cases per million. Common non-iatrogenic causes include autoimmunity, infections and infiltrations. We describe a case of acute adrenal insufficiency secondary to an unusual cause.A 77-year old female was admitted under the surgeons with abdominal pain and pyrexia. Abdominal ultrasonography showed large stones within a thickened gallbladder and a pr...

ea0050ep039 | Bone and Calcium | SFEBES2017

Sclerotic Bone Metastases Diagnosed on DXA

Pickard Victoria , Goh Tee Lin , Kueh Christopher Jiaw Liang , Gallagher Andrew

Case History: A 79 year old gentleman sustained a traumatic fracture of his left humerus in November 2016. Given his age and non-union of fracture, he was referred for a dual X-ray absorptiometry (DXA) scan in May 2017. This demonstrated markedly elevated bone mineral density (BMD) and subsequent investigation was performed.The patient has a past medical history of type 2 diabetes mellitus, hypertension, asthma and kidney stones. H...

ea0050ep105 | Thyroid | SFEBES2017

A case of Graves’ disease refractory to radioactive iodine

Abouglila Kamal , Devine Kerri

We report a rare case of hyperthyroidism secondary to GravesÂ’ disease which failed to respond to three consecutive therapeutic doses of radioactive iodine 131.This 62 year old gentleman with a history of ischaemic heart disease was first referred to endocrine services in September 2014 with classical symptomatic hyperthyroidism. He described fatigue, significant weight loss of 3.5 stones, sweating, palpitations and heat intolerance ove...

ea0086p37 | Bone and Calcium | SFEBES2022

The management of autosomal dominant hypoparathyroidism with CaSR mutation in pregnancy and breastfeeding

Halim Sandra , Rahim Haaris , Avari Parizad , Mulla Kaenat , Freudenthal Bernard , N Comninos Alexander , Agha-Jaffar Rochan , Robinson Stephen , Cox Jeremy

Autosomal dominant hypoparathyroidism (ADH) is caused by gain-of-function mutations in the calcium-sensing receptor (CaSR), increasing its sensitivity to extracellular calcium, suppressing PTH and resulting in hypocalcaemia. In contrast to idiopathic hypoparathyroidism, treatment to correct serum calcium results in high urine calcium excretion, causing nephrocalcinosis, stones and renal impairment. Unlike surgical hypoparathyroidism where calcium should be maintained, patients...

ea0086p39 | Bone and Calcium | SFEBES2022

An unusual case of severe hypercalcaemia due to treatment resistant Graves’ disease

Thuzar Aung Ei , Sheokand Ajasra , Prakash Narayanan Ram , Balafshan Tala , McNulty Sid , Furlong Niall , Bujawansa Sumudu

A 32-years-old lady was admitted with raised calcium. She had palpitation, sweating, 3 stones weight loss and neck swelling. She was diagnosed with GravesÂ’ disease 5 months ago. Her mother had history of thyroid disease but no family history of hypercalcaemia. She had a small goitre and lid lag on examination. On admission, adjusted calcium was 3.04 mmol/l. PTH was < 0.5 pmol/l. Phosphate, vitamin-D, kidney functions, cortisol, myeloma screen and ACE levels ...

ea0086p186 | Bone and Calcium | SFEBES2022

Primary Hyperparathyroidism Audit: Does routine Ultrasound Kidneys add value?

Eyzaguirre Valencia Mario , Chandrashekar Sunaya , Chinnasamy Eswari , Kyaw Ye , Theofanoyiannis Panayiotis , Muralidhara Koteshwara , Sivakumaran Darshi , Ofo Enyinnaya , Yella Ramesh

Introduction: Primary hyperparathyroidism (PHPT) is a commonly encountered endocrine pathology. Asymptomatic renal stones have been reported in 7-22% of patients. NICE guideline (NG132) published in May 2019 on PHPT recommends renal US in all patients. The value of renal ultrasound for all patients with PHPT has been debated. This audit aims to compare local practice to NICE guideline (NG132) and to see if a tailored approach for renal ultrasound would be safe, practical and e...

ea0086p320 | Bone and Calcium | SFEBES2022

Primary Hyperparathyroidism in a patient with Alport syndrome

Wahid Alam , Ramalingam Satheekshan , Ross Callum , Srinivasan Ramalingam

A 50 years old man was seen in the Endocrine clinic with elevated calcium (2.80 mmol/l, normal 2.20-2.60) and Parathyroid hormone (10.7 pmol/l, normal 1.6-6.9) levels. His medical background includes Alport Syndrome, Renal Allografts (1st 1990, 2nd 2000 and 3rd 03/11/2005), and Osteopenia on DEXA scan in February 2020. He did not have any renal stones in the past. There was no family history of hypercalcemia. He was on Vitamin D 1000 Units daily (Vitamin D 55 nmol/l, normal 50...

ea0086p246 | Neuroendocrinology and Pituitary | SFEBES2022

A novel presentation of primary hyperparathyroidism for the Val804Met mutation

Yadav Jahnavi , Mehta Rubin , Avari Parizad , Freudenthal Bernard , Mulla Kaenat , Mistry Kieran , MacEacharn William , Cox Jeremy

Background: Multiple endocrine neoplasia type 2 (MEN2) is a group of pleomorphic syndromes which infer a susceptibility to several endocrine conditions. The RET Val804Met mutation is classified as a moderate-risk mutation for familial medullary thyroid cancer (MTC), without the other components of MEN2 syndromes. However, here we describe a rare case of a gentleman with RET p.V804M, presenting with primary hyperparathyroidism (PHPT) and no evidence of MTC.<p class="abstext...